The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management
Juan Pan,1 Chao Ye,2 Ling-Zhi Zhou,1 Zu-Yi Li,1 Juan Wang,2 Xin He,2 Shen-Jue Chen,2 Guang-Qing Zhou2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, People’s Republic of China; 2Department of Pharmacy, The Third Hospital of Changsha, Changsha, Hunan, Peop...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-07-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-spectrum-of-tigecycline-induced-pancreatitis-in-clinical-character-peer-reviewed-fulltext-article-IJGM |
| _version_ | 1827903754732568576 |
|---|---|
| author | Pan J Ye C Zhou LZ Li ZY Wang J He X Chen SJ Zhou GQ |
| author_facet | Pan J Ye C Zhou LZ Li ZY Wang J He X Chen SJ Zhou GQ |
| author_sort | Pan J |
| collection | DOAJ |
| description | Juan Pan,1 Chao Ye,2 Ling-Zhi Zhou,1 Zu-Yi Li,1 Juan Wang,2 Xin He,2 Shen-Jue Chen,2 Guang-Qing Zhou2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, People’s Republic of China; 2Department of Pharmacy, The Third Hospital of Changsha, Changsha, Hunan, People’s Republic of ChinaCorrespondence: Chao Ye, Department of Pharmacy, The Third Hospital of Changsha, No. 176 Laodong West Road, Tianxin District, Changsha, Hunan, 410015, People’s Republic of China, Email yechao1234256@163.com Ling-Zhi Zhou, Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, No. 67, Beizheng Middle Road, Changsha, Hunan, 410300, People’s Republic of China, Email 1024482174@qq.comIntroduction: Tigecycline-induced acute pancreatitis (AP) has been frequently increasingly reported in solid organ transplant patients. This review aimed to summarize the characteristics, possible mechanisms, and management of tigecycline-induced AP.Methods: Case reports of tigecycline-induced AP published in Chinese or English were collected until February 2023 for retrospective analysis.Results: Thirty-four patients from 29 articles were included. Fifteen patients (46.9%) had solid organ transplantation, and 4 patients (12.5%) had malignant tumors. Twenty-five patients (89.3%) received a recommended maintenance dose of tigecycline (50 mg q12 h). The median age was 50 years (range 9– 87). Compared to the nontransplant patients, the median age of the transplant patients was significantly younger, 44 years (range 12.5– 61) versus 57.5 years (range 9– 87) (P=0.03). The median time of symptom onset was 7 days (range 2– 29), and 91.2% (31/34) were less than 14 days. Typical initial symptoms included abdominal pain (90.6%), nausea (46.9%), vomiting (43.8%), and abdominal distention (21.9%). Most cases were accompanied by elevated levels of pancreatic enzymes. The main radiological features included edematous infiltrate and acute pancreatitis on computed tomography (CT) scan and abdominal ultrasound. Except for one patient who continued tigecycline treatment, all patients discontinued treatment and received symptomatic support such as fasting, acid suppression, and enzyme suppression. The median time to recover pancreatic enzymes to the normal range was 5 days (range 1– 43), and the median time to relieve symptoms was 4 days (range 1– 12). Four patients died, of whom two died of severe pancreatitis complications and two of cardiogenic shock and septicemia.Conclusion: Tigecycline-induced AP was a rare and serious complication that occurred mainly within two weeks of the medication. This serious side effect should be kept in mind while treating severe infections especially in transplant recipients.Keywords: tigecycline, pancreatitis, adverse drug reaction, solid organ transplantation |
| first_indexed | 2024-03-13T00:18:07Z |
| format | Article |
| id | doaj.art-2228339156df43288450adf2a47e8980 |
| institution | Directory Open Access Journal |
| issn | 1178-7074 |
| language | English |
| last_indexed | 2024-03-13T00:18:07Z |
| publishDate | 2023-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of General Medicine |
| spelling | doaj.art-2228339156df43288450adf2a47e89802023-07-11T19:01:06ZengDove Medical PressInternational Journal of General Medicine1178-70742023-07-01Volume 162971297985071The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and ManagementPan JYe CZhou LZLi ZYWang JHe XChen SJZhou GQJuan Pan,1 Chao Ye,2 Ling-Zhi Zhou,1 Zu-Yi Li,1 Juan Wang,2 Xin He,2 Shen-Jue Chen,2 Guang-Qing Zhou2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, People’s Republic of China; 2Department of Pharmacy, The Third Hospital of Changsha, Changsha, Hunan, People’s Republic of ChinaCorrespondence: Chao Ye, Department of Pharmacy, The Third Hospital of Changsha, No. 176 Laodong West Road, Tianxin District, Changsha, Hunan, 410015, People’s Republic of China, Email yechao1234256@163.com Ling-Zhi Zhou, Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, No. 67, Beizheng Middle Road, Changsha, Hunan, 410300, People’s Republic of China, Email 1024482174@qq.comIntroduction: Tigecycline-induced acute pancreatitis (AP) has been frequently increasingly reported in solid organ transplant patients. This review aimed to summarize the characteristics, possible mechanisms, and management of tigecycline-induced AP.Methods: Case reports of tigecycline-induced AP published in Chinese or English were collected until February 2023 for retrospective analysis.Results: Thirty-four patients from 29 articles were included. Fifteen patients (46.9%) had solid organ transplantation, and 4 patients (12.5%) had malignant tumors. Twenty-five patients (89.3%) received a recommended maintenance dose of tigecycline (50 mg q12 h). The median age was 50 years (range 9– 87). Compared to the nontransplant patients, the median age of the transplant patients was significantly younger, 44 years (range 12.5– 61) versus 57.5 years (range 9– 87) (P=0.03). The median time of symptom onset was 7 days (range 2– 29), and 91.2% (31/34) were less than 14 days. Typical initial symptoms included abdominal pain (90.6%), nausea (46.9%), vomiting (43.8%), and abdominal distention (21.9%). Most cases were accompanied by elevated levels of pancreatic enzymes. The main radiological features included edematous infiltrate and acute pancreatitis on computed tomography (CT) scan and abdominal ultrasound. Except for one patient who continued tigecycline treatment, all patients discontinued treatment and received symptomatic support such as fasting, acid suppression, and enzyme suppression. The median time to recover pancreatic enzymes to the normal range was 5 days (range 1– 43), and the median time to relieve symptoms was 4 days (range 1– 12). Four patients died, of whom two died of severe pancreatitis complications and two of cardiogenic shock and septicemia.Conclusion: Tigecycline-induced AP was a rare and serious complication that occurred mainly within two weeks of the medication. This serious side effect should be kept in mind while treating severe infections especially in transplant recipients.Keywords: tigecycline, pancreatitis, adverse drug reaction, solid organ transplantationhttps://www.dovepress.com/the-spectrum-of-tigecycline-induced-pancreatitis-in-clinical-character-peer-reviewed-fulltext-article-IJGMtigecyclinepancreatitisadverse drug reactionsolid organ transplantation |
| spellingShingle | Pan J Ye C Zhou LZ Li ZY Wang J He X Chen SJ Zhou GQ The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management International Journal of General Medicine tigecycline pancreatitis adverse drug reaction solid organ transplantation |
| title | The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management |
| title_full | The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management |
| title_fullStr | The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management |
| title_full_unstemmed | The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management |
| title_short | The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management |
| title_sort | spectrum of tigecycline induced pancreatitis in clinical characteristics diagnosis and management |
| topic | tigecycline pancreatitis adverse drug reaction solid organ transplantation |
| url | https://www.dovepress.com/the-spectrum-of-tigecycline-induced-pancreatitis-in-clinical-character-peer-reviewed-fulltext-article-IJGM |
| work_keys_str_mv | AT panj thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT yec thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT zhoulz thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT lizy thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT wangj thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT hex thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT chensj thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT zhougq thespectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT panj spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT yec spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT zhoulz spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT lizy spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT wangj spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT hex spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT chensj spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement AT zhougq spectrumoftigecyclineinducedpancreatitisinclinicalcharacteristicsdiagnosisandmanagement |